{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:27:48Z","timestamp":1787020068945,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recently, we face a surge in the fast-forward Coronavirus Disease 2019 (COVID-19) pandemic with nearly 170\u00a0million confirmed cases and almost 3.5\u00a0million confirmed deaths at the end of May 2021. Obesity, also known as the pandemic of the 21st century, has been evolving as an adverse prognostic marker. Obesity is associated with a higher risk of being SARS-CoV-2-positive (46%), as well as hospitalization (113%) and death (48%) due to COVID-19. It is especially true for subjects with morbid obesity. Also, observational studies suggest that in the case of COVID-19, no favorable \u201cobesity paradox\u201d is observed. Therefore, it is postulated to introduce a new entity, i.e., coronavirus disease-related cardiometabolic syndrome (CIRCS). In theory, it applies to all stages of COVID-19, i.e., prevention, acute proceedings (from COVID-19 diagnosis to resolution or three months), and long-term outcomes. Consequently, lifestyle changes, glycemic control, and regulation of the renin-angiotensin-aldosterone pathway have crucial implications for preventing and managing subjects with COVID-19. Finally, it is crucial to use cardioprotective drugs such as angiotensin-converting enzyme inhibitors\/angiotensin II receptor blockers and statins. Nevertheless, there is the need to conduct prospective studies and registries better to evaluate the issue of obesity in COVID-19 patients.<\/jats:p>","DOI":"10.1186\/s12872-021-02134-y","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:03:11Z","timestamp":1625547791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The vicious cycle: a history of obesity and COVID-19"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-5611","authenticated-orcid":false,"given":"Jacek","family":"Bil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mo\u017ce\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"2134_CR1","unstructured":"WHO. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\u00a0(2020). Accessed 27 Nov 2020."},{"issue":"1","key":"2134_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12872-020-01758-w","volume":"20","author":"J Li","year":"2020","unstructured":"Li J, Zhang Y, Wang F, et al. Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19). BMC Cardiovasc Disord. 2020;20(1):479.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2134_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12872-020-01658-z","volume":"20","author":"C Sardu","year":"2020","unstructured":"Sardu C, Marfella R, Maggi P, et al. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord. 2020;20(1):373.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2134_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12872-020-01816-3","volume":"21","author":"A Silverio","year":"2021","unstructured":"Silverio A, Di Maio M, Citro R, et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc Disord. 2021;21(1):23.","journal-title":"BMC Cardiovasc Disord"},{"key":"2134_CR5","doi-asserted-by":"publisher","first-page":"e13313","DOI":"10.1111\/eci.13313","volume":"50","author":"A Post","year":"2020","unstructured":"Post A, Bakker SJL, Dullaart RPF. Obesity, adipokines and COVID-19. Eur J Clin Investig. 2020;50:e13313.","journal-title":"Eur J Clin Investig"},{"key":"2134_CR6","doi-asserted-by":"crossref","unstructured":"Pearl RL, Schulte EM. Weight bias during the COVID-19 pandemic. Curr Obes Rep.\u00a02021;10(2):181\u2013190.","DOI":"10.1007\/s13679-021-00432-2"},{"issue":"11","key":"2134_CR7","doi-asserted-by":"publisher","first-page":"e13128","DOI":"10.1111\/obr.13128","volume":"21","author":"BM Popkin","year":"2020","unstructured":"Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):e13128.","journal-title":"Obes Rev"},{"issue":"7","key":"2134_CR8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/dc20-0576","volume":"43","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen F, Wang T, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392\u20138.","journal-title":"Diabetes Care"},{"issue":"7","key":"2134_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/oby.22831","volume":"28","author":"A Simonnet","year":"2020","unstructured":"Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020;28(7):1195\u20139.","journal-title":"Obesity (Silver Spring)"},{"key":"2134_CR10","doi-asserted-by":"crossref","unstructured":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369(m1966.","DOI":"10.1136\/bmj.m1966"},{"key":"2134_CR11","doi-asserted-by":"crossref","unstructured":"Yates T, Zaccardi F, Islam N, et al. Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID-19: analysis of the ISARIC CCP-UK cohort. Obesity (Silver Spring). 2021;29(7):1223\u201330.","DOI":"10.1002\/oby.23178"},{"issue":"10","key":"2134_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.15585\/mmwr.mm7010e4","volume":"70","author":"L Kompaniyets","year":"2021","unstructured":"Kompaniyets L, Goodman AB, Belay B, et al. Body Mass Index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death\u2014United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355\u201361.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2134_CR13","doi-asserted-by":"publisher","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","volume":"16","author":"A Booth","year":"2021","unstructured":"Booth A, Reed AB, Ponzo S, et al. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS ONE. 2021;16(3):e0247461.","journal-title":"PLoS ONE"},{"key":"2134_CR14","doi-asserted-by":"crossref","unstructured":"Abumayyaleh M, Nunez Gil IJ, El-Battrawy I, et al. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry. Obes Res Clin Pract. 2021;15(3):275\u201380.","DOI":"10.1016\/j.orcp.2021.02.008"},{"key":"2134_CR15","doi-asserted-by":"crossref","unstructured":"Landecho MF, Marin-Oto M, Recalde-Zamacona B, Bilbao I, Fruhbeck G. Obesity as an adipose tissue dysfunction disease and a risk factor for infections\u2014Covid-19 as a case study. Eur J Intern Med. 2021;S0953\u20136205(21)00097\u20132.","DOI":"10.1016\/j.ejim.2021.03.031"},{"issue":"10","key":"2134_CR16","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666\u201387.","journal-title":"Cardiovasc Res"},{"key":"2134_CR17","doi-asserted-by":"crossref","unstructured":"Sarver DC, Wong GW. Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: implications for COVID-19. Biochem Biophys Res Commun. 2020;538:92\u201396.","DOI":"10.1016\/j.bbrc.2020.10.066"},{"key":"2134_CR18","doi-asserted-by":"crossref","unstructured":"Shah H, Khan MSH, Dhurandhar NV, Hegde V. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19. Acta Diabetol. 2021;58(7):831\u201343.","DOI":"10.1007\/s00592-020-01636-z"},{"key":"2134_CR19","doi-asserted-by":"publisher","first-page":"m4130","DOI":"10.1136\/bmj.m4130","volume":"371","author":"E Mahase","year":"2020","unstructured":"Mahase E. Covid-19: Why are age and obesity risk factors for serious disease? BMJ. 2020;371:m4130.","journal-title":"BMJ"},{"issue":"17","key":"2134_CR20","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.jacc.2020.07.069","volume":"76","author":"JI Mechanick","year":"2020","unstructured":"Mechanick JI, Rosenson RS, Pinney SP, et al. Coronavirus and cardiometabolic syndrome: JACC focus seminar. J Am Coll Cardiol. 2020;76(17):2024\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2134_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and Angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671\u201381.","journal-title":"Circ Res"},{"key":"2134_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","volume":"134","author":"CS Kow","year":"2020","unstructured":"Kow CS, Hasan SS. Meta-analysis of effect of statins in patients with COVID-19. Am J Cardiol. 2020;134:153\u20135.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2134_CR23","doi-asserted-by":"publisher","first-page":"e12439","DOI":"10.1111\/cob.12439","volume":"11","author":"A Belancic","year":"2021","unstructured":"Belancic A, Kresovic A, Troskot Dijan M. Glucagon-like peptide-1 receptor agonists in the era of COVID-19: friend or foe? Clin Obes. 2021;11(2):e12439.","journal-title":"Clin Obes"},{"key":"2134_CR24","doi-asserted-by":"publisher","first-page":"6920620","DOI":"10.1155\/2018\/6920620","volume":"2018","author":"J Fandino","year":"2018","unstructured":"Fandino J, Vaz AA, Toba L, et al. Liraglutide enhances the activity of the ACE-2\/Ang(1\u20137)\/Mas receptor pathway in lungs of male pups from food-restricted mothers and prevents the reduction of SP-A. Int J Endocrinol. 2018;2018:6920620.","journal-title":"Int J Endocrinol"},{"key":"2134_CR25","doi-asserted-by":"crossref","unstructured":"de Luis Roman DA, Izaola O, Primo Martin D, et al. Effect of lockdown for COVID-19 on self-reported body weight gain in a sample of obese patients. Nutr Hosp. 2020;37(6):1232\u201337.","DOI":"10.20960\/nh.03307"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02134-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02134-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02134-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:12:10Z","timestamp":1625548330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02134-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2134"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02134-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}